『2 Minutes with Joey - MRNA Stock News』のカバーアート

2 Minutes with Joey - MRNA Stock News

2 Minutes with Joey - MRNA Stock News

著者： 2 Minutes with Joey
無料で聴く

Two minutes with Joey on Moderna (MRNA) - a quick daily recap of what the stock did today and why, in plain English. Information and entertainment only, not financial advice.Copyright 2 Minutes with Joey 社会科学
エピソード
  • MRNA Today - Aug 13: Bank of America Sells Shares

    MRNA Today - Aug 13: Bank of America Sells Shares
    2026/08/13
    Hey there! It’s Joey here, your friendly neighborhood investor, breaking down what went down with Moderna today. So, MRNA had a pretty chill day, just barely moved up, closing at 64 bucks and change. Not a crazy jump, but hey, at least it’s not in the red!

    Now, let’s get into what’s going on. The big news today? Bank of America decided to sell off a hefty chunk of Moderna shares—like, almost 400,000 of them! Yeah, that one stung a bit for the stock. When big players like that start selling, it can freak people out, and some folks hit the sell button fast. So, there was definitely some nervous energy in the air.

    On the flip side, we also heard from Capital World Investors. They filed a report saying they have a 5.6% stake in Moderna. So, it’s not all doom and gloom. It shows there’s still interest from some heavy hitters. But with the Bank of America news, it kind of overshadowed that positive vibe.

    And here’s something else that caught my eye. The CDC is keeping quiet about a report on COVID-19 vaccine effectiveness. That’s kind of a big deal, especially with all the chatter around vaccines and health stuff lately. Also, Moderna’s got some mRNA bird flu vaccine in late-stage testing, which could be a big step forward for them. So, they’re still in the game, just dealing with some market drama.

    To wrap it up, Moderna had a slow day, mostly influenced by that big sell-off from Bank of America. But there’s still some positive movement in the background with other investors and ongoing projects. Just remember, this info is for your entertainment, not financial advice. Catch you later!
    続きを読む 一部表示
    2 分
  • MRNA Today - Aug 12: FDA Approves mRNA Flu Vaccine

    MRNA Today - Aug 12: FDA Approves mRNA Flu Vaccine
    2026/08/12
    Hey there! It’s Joey, your friendly stock guy, breaking down the day for ya. Today we're talking about Moderna, and it was a green day for them—up about 2%!

    So, here’s what went down. Moderna had a pretty solid day, gaining some traction after the FDA gave the thumbs up for their first mRNA flu vaccine. That news definitely got some folks excited. But even with that good news, the stock didn’t go wild. It kinda felt like it was just cruising along, right? Like, yeah, it got a boost, but it wasn’t the kind of explosion you might expect from a big announcement.

    Now, why the mixed vibes? Well, while the FDA approval is huge, it's also part of a bigger picture. The market's been pretty jittery lately, with other news swirling around. For instance, there was chatter about the CDC not publishing a report on COVID-19 vaccine effectiveness. That’s a bit of a head-scratcher and could leave people feeling uncertain. Plus, there was a report about a former pharmacy president getting sentenced for a big kickback scheme. Yikes! So, yeah, the context around the stock wasn’t all sunshine and rainbows today.

    On top of that, there’s been some selling pressure, too. Bank of America sold a chunk of shares, which might have made some investors a bit nervous. When big players like that start unloading, it can make people hit the sell button fast, even if the news is good.

    Looking ahead, there's a lot of buzz around Moderna's mRNA technology, especially with that bird flu vaccine hitting late-stage testing. It’s like Moderna's trying to be the go-to player for all things mRNA, and that could open up some exciting doors down the line.

    So, to wrap it up, Moderna had a decent day, boosted by the FDA’s green light for their flu vaccine, but the market’s been a bit shaky with other news making waves. Just remember, this is all for info and fun, not financial advice. Catch you later!
    続きを読む 一部表示
    2 分
  • MRNA Today - Aug 11: Flu Shot News Moves Stock

    MRNA Today - Aug 11: Flu Shot News Moves Stock
    2026/08/11
    Hey there! It’s Joey, your friendly investor buddy, here to break down what went down with Moderna today. So, MRNA was in the green today, up about one percent. Not a huge jump, but hey, we’ll take it!

    So, here’s the scoop. Moderna had a pretty chill day in the market, with volume hanging right around average. But the buzz? It was all about their flu shot news. Yeah, people were talking about how they’re stepping up their game in the flu vaccine department. It seems like folks are getting a bit more excited about the potential there, which gave the stock a little boost.

    Now, why the excitement? Well, it looks like there's a growing interest in flu shots, especially as we head into the fall season. With COVID still lingering, people are more aware of their health and looking for ways to stay protected. Moderna’s flu shot is catching some attention, and that’s likely why people decided to hit the buy button instead of selling. It’s all about that seasonal vibe, you know?

    Oh, and here’s a tidbit: there’s chatter about how Moderna is still on the sidelines with a few things, but if they hit certain targets, they might just change their game. So, keep an eye on that. It’s like waiting for that perfect moment in a video game to strike!

    To wrap it all up, it was a decent day for Moderna, thanks to that flu shot news. Just remember, I’m here to keep you informed and entertained, but this isn’t financial advice. Catch you later!
    続きを読む 一部表示
    1 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません